CA
NZ
UK
AU
IND
US
Padmanabh P. Bhatt, SVP of IP and Chief Scientific Officer at Supernus, Inc., filed a Form 4 on November 4, 2026, disclosing changes in beneficial ownership resulting from the November 2, 2026 merger between Supernus Pharmaceuticals, Inc. and Indivior Pharmaceuticals, Inc.
Director Bethany Sensenig filed a Form 4 with the SEC on November 4, 2026, disclosing the automatic conversion of her Supernus Pharmaceuticals equity awards into Supernus, Inc. equity awards following the completion of a merger on November 2, 2026.
Director Carrolee Barlow filed a Form 4 with the SEC on November 4, 2026, disclosing changes in beneficial ownership of Supernus, Inc. common stock and equity awards resulting from the merger effective November 2, 2026, in which Indivior Pharmaceuticals, Inc. merged with Supernus Pharmaceuticals, …
Carrolee Barlow, a newly appointed director of Supernus, Inc., filed a Form 3 initial statement of beneficial ownership on November 4, 2026, disclosing no beneficial ownership of company securities as of the event date of November 2, 2026.
Padmanabh P. Bhatt, newly appointed SVP and Chief Scientific Officer of Supernus, Inc., filed an initial statement of beneficial ownership on November 4, 2026, disclosing no beneficial ownership of company securities as of the event date of November 2, 2026.
Frank Mottola, SVP and Chief Technology Operations Officer at Supernus, Inc., filed an initial statement of beneficial ownership on November 4, 2026, disclosing no securities held as of the November 2, 2026 event date that triggered the filing.
Timothy C. Dec, Senior Vice President and Chief Financial Officer of Supernus, Inc., filed an initial statement of beneficial ownership on November 4, 2026, disclosing no beneficial ownership of company securities as of November 2, 2026.
Menassie Taddese, a newly appointed director of Xeris Biopharma Holdings, Inc., filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities held as of the event date of November 2, 2026.
William Todd Horich, SVP and Chief Commercial Officer of Supernus, Inc., filed a Form 3 initial statement of beneficial ownership on November 4, 2026, disclosing no securities held as of the date he became subject to reporting obligations.
Jonathan Rubin, SVP and Chief Medical Officer of Supernus, Inc., filed a Form 3 initial statement of beneficial ownership on November 4, 2026, disclosing no securities of the company held as of the date he became subject to reporting obligations.
Please wait processing your request...